WASHINGTON -- Millions of dollars could be at stake in a lawsuit in Nevada that alleges the state's Medicaid program was overcharged for two of Merck and Co.'s biggest selling drugs.
Nevada's attorney general and a former Merck district sales manager allege that Merck failed to give Medicaid the same steep discounts for Vioxx and Zocor that it gave hundreds of hospitals nationwide.
Zocor, which treats high cholesterol, is Merck's biggest drug, with $5.2 billion in sales last year. The arthritis drug Vioxx, which Merck has taken off the market, had about $2.5 billion in annual sales.
more...
http://www.newsday.com/news/politics/wire/sns-ap-medicaid-lawsuit,0,3567065.story?coll=sns-ap-politics-headlines